Ostatní
Návod 
Ultragenyx Pharmaceutical Inc.
RARE
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
2.9B
Obrat
1B
Zisk
-1B
Aktiva
1B
Dluh
1B
ROE
0%
ROA
0%
PE
-3
PS
3
Cena 1R
18-47
⌀ Cena
32.42
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
12-02-2026
Poslední dividenda
Profil
Společnost Ultragenyx Pharmaceutical Inc., biofarmaceutická společnost, se zaměřuje na identifikaci, získání, vývoj a komercializaci nových produktů pro léčbu vzácných a ultravzácných genetických onemocnění v Severní Americe, Evropě a mezinárodně. Mezi jeho biologické produkty patří Crysvita (burosumab), protilátka cílící na fibroblastový růstový faktor 23 pro léčbu hypofosfatémie vázané na X, stejně jako osteomalacie vyvolaná nádorem; Mepsevii, enzymová substituční terapie pro léčbu dětí a dospělých s mukopolysacharidózou VII; Dojolvi pro léčbu oxidačních poruch mastných kyselin s dlouhým řetězcem; a Evkeeza (evinacumab) pro léčbu homozygotní familiární hypercholesterolemie. Kandidatury produktů společnosti zahrnují DTX401, adenem asociovaný virus 8 (AAV8), genovou terapii klinického kandidáta pro léčbu pacientů s glykogenní paměťovou chorobou typu Ia; DTX301, genovou terapii AAV8 pro léčbu pacientů s ornitin-transkarbamylázou; UX143, lidskou monoklonální protilátku pro léčbu osteogenesis imperfecta; GTX-102, antisense oligonukleotid pro léčbu Angelmanova syndromu; UX701, pro léčbu Wilsonovy choroby; a UX053 pro léčbu glykogenové paměťové choroby typu III. Společnost Ultragenyx Pharmaceutical Inc. spolupracuje a má licenční smlouvu s Kyowa Kirin Co., Ltd.; Univerzita Saint Louis; Baylor Research Institute; REGENXBIO Inc.; Bayer Healthcare LLC; GeneTx; Mereo; Pennsylvania; Arcturus Therapeutics Holdings Inc., Solid Biosciences Inc.; a Daiichi Sankyo Co., Ltd. Společnost Ultragenyx Pharmaceutical Inc. byla založena v roce 2010 a sídlí v Novatu v Kalifornii.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
1294
Založení
2014-01-31
Podobné společnosti
$ 21.93
- $ 0.19
$ 38.12
- $ 0.13
$ 55.95
+ $ 1.24
$ 33.60
+ $ 1.26
$ 30.79
+ $ 0.55
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 672.7 | 673.0 | 560.2 | 434.2 | 363.3 | 351.4 | 271.0 | 103.7 | 51.5 | 2.6 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cost of Revenues | 108.7 | 109.0 | 76.7 | 45.2 | 28.3 | 16.0 | 6.1 | 9.0 | 1.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Gross Profit | 564.1 | 564.0 | 483.5 | 389.0 | 335.0 | 335.4 | 264.9 | 94.7 | 50.3 | 2.6 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 207.0 | 159.9 | 166.5 | 139.3 | 164.9 | 139.5 | 147.0 | 108.8 | 127.4 | 98.1 | |
| Cost of Revenues | 29.0 | 28.0 | 23.0 | 28.7 | 16.9 | 21.0 | 21.3 | 17.5 | 12.1 | 11.0 | |
| Gross Profit | 178.0 | 131.9 | 143.5 | 110.6 | 148.0 | 118.5 | 125.7 | 91.3 | 115.3 | 87.1 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 648.4 | 705.8 | 497.2 | 412.1 | 357.4 | 294.0 | 231.6 | 183.2 | 114.7 | 46.0 | 27.8 | 12.6 | 4.7 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 309.8 | 278.1 | 220.0 | 182.9 | 161.5 | 127.7 | 99.9 | 64.9 | 33.0 | 10.8 | 4.5 | 3.3 | 1.8 | |
| Depreciation & Amortization | 35.0 | 35.0 | 35.5 | 26.0 | 9.5 | 0.2 | 7.6 | 12.5 | 19.5 | 5.8 | 3.4 | 1.4 | 0.7 | 0.4 | 0.3 | 0.0 | |
| Total Operating Expenses | 1,099.8 | 1,099.0 | 1,019.5 | 958.2 | 983.9 | 717.1 | 595.0 | 518.9 | 421.7 | 331.6 | 248.1 | 147.7 | 56.8 | 32.3 | 16.0 | 6.6 | |
| Operating Income | -535.7 | -535.0 | -536.0 | -569.2 | -648.9 | -381.7 | -330.1 | -424.2 | -371.4 | -328.9 | -248.0 | -147.7 | -56.8 | -32.3 | -16.0 | -6.6 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 160.6 | 157.2 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 76.8 | 74.9 | ||
| Depreciation & Amortization | 8.8 | 8.6 | 8.6 | 9.0 | 9.1 | 8.8 | 8.9 | 8.8 | 8.2 | 7.2 | ||
| Total Operating Expenses | 292.0 | 302.8 | 251.4 | 253.6 | 270.3 | 250.5 | 242.1 | 256.6 | 237.4 | 232.2 | ||
| Operating Income | -114.0 | -170.9 | -107.9 | -142.9 | -122.3 | -132.0 | -116.4 | -165.3 | -122.0 | -145.1 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 25.0 | 25.0 | 36.5 | 26.7 | 11.1 | 1.9 | 7.0 | 13.2 | 9.5 | 4.1 | 3.8 | 2.3 | 0.6 | 0.2 | 0.0 | 0.0 | |
| Interest Expense | 61.5 | 62.0 | 63.0 | 66.0 | 43.0 | 29.4 | 33.3 | 1.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | |
| Other Expense | -35.6 | -36.0 | -31.6 | -39.3 | -52.8 | -71.2 | 144.8 | 24.7 | 174.3 | 10.6 | 2.2 | -0.2 | -3.0 | -3.0 | -0.4 | 0.0 | |
| IBT | -571.3 | -571.0 | -567.6 | -608.5 | -701.7 | -453.0 | -185.4 | -399.4 | -197.1 | -318.3 | -245.8 | -145.6 | -59.8 | -35.1 | -16.3 | -6.8 | |
| Income Tax Expense | 4.1 | 4.0 | 1.6 | -1.8 | 5.7 | 1.0 | 1.2 | 3.3 | 0.5 | -16.2 | 0.0 | -2.3 | -0.7 | -3.0 | -0.4 | 0.2 | |
| Net Income | -575.4 | -575.0 | -569.2 | -606.6 | -707.4 | -454.0 | -186.6 | -402.7 | -197.6 | -302.1 | -245.9 | -145.6 | -59.8 | -35.1 | -16.3 | -6.8 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 6.5 | 5.9 | 5.8 | 6.8 | 9.6 | 10.7 | 7.4 | 8.8 | 8.6 | 5.9 | ||
| Interest Expense | 19.0 | 14.1 | 14.0 | 14.3 | 15.5 | 15.7 | 16.0 | 15.8 | 17.3 | 17.7 | ||
| Other Expense | -14.0 | -8.7 | -6.1 | -6.8 | -11.1 | -1.2 | -14.4 | -4.9 | -4.8 | -13.9 | ||
| IBT | -128.0 | -179.5 | -114.0 | -149.8 | -133.4 | -133.2 | -130.7 | -170.2 | -126.9 | -159.0 | ||
| Income Tax Expense | 1.0 | 0.9 | 0.9 | 1.3 | 0.0 | 0.3 | 0.9 | 0.5 | -3.7 | 0.7 | ||
| Net Income | -129.0 | -180.4 | -115.0 | -151.1 | -133.4 | -133.5 | -131.6 | -170.7 | -123.2 | -159.6 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-8.25 | $-10.12 | $-6.70 | $-3.07 | $-7.12 | $-3.97 | $-7.12 | $-6.21 | $-3.96 | $-2.08 | $-1.21 | $-0.71 | $-0.30 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-8.25 | $-10.12 | $-6.70 | $-3.07 | $-7.12 | $-3.97 | $-7.12 | $-6.21 | $-3.96 | $-2.08 | $-1.21 | $-0.71 | $-0.30 | |
| Shares Outstanding | 99.9 | 98.6 | 90.5 | 73.5 | 69.9 | 67.8 | 60.8 | 56.6 | 49.8 | 42.5 | 39.6 | 36.8 | 28.8 | 29.1 | 23.1 | 23.1 | |
| Diluted Shares Outstanding | 99.9 | 98.6 | 90.5 | 73.5 | 69.9 | 67.8 | 60.8 | 56.6 | 49.8 | 42.5 | 39.6 | 36.8 | 28.8 | 29.1 | 23.1 | 23.1 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-1.52 | $-2.23 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-1.52 | $-2.23 | ||
| Shares Outstanding | 99.9 | 99.8 | 98.5 | 96.3 | 95.7 | 95.5 | 86.6 | 84.3 | 81.1 | 71.7 | ||
| Diluted Shares Outstanding | 99.9 | 99.8 | 98.5 | 96.3 | 95.7 | 95.5 | 86.6 | 84.3 | 81.1 | 71.7 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 486.9 | 173.7 | 213.6 | 132.9 | 307.6 | 713.5 | 433.6 | 113.4 | 100.5 | 161.1 | 93.6 | 24.3 | 7.4 | 86.2 | 10.6 | |
| Short Term Investments | 283.1 | 436.3 | 363.6 | 614.8 | 432.6 | 488.0 | 321.6 | 346.3 | 134.0 | 219.0 | 343.4 | 163.2 | 46.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 770.0 | 610.0 | 577.2 | 896.7 | 999.1 | 1,212.0 | 760.4 | 459.7 | 244.5 | 498.1 | 437.0 | 187.5 | 53.4 | 86.2 | 10.6 | |
| Accounts Receivable | 108.3 | 121.8 | 73.4 | 40.4 | 28.4 | 23.1 | 32.8 | 12.7 | 5.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| Inventory | 40.1 | 45.0 | 34.0 | 26.8 | 16.2 | 13.0 | 11.5 | 7.1 | 0.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Assets | 46.2 | 40.3 | 47.6 | 68.9 | -187.2 | 47.1 | 46.2 | 42.9 | 29.2 | 21.5 | 13.2 | 5.9 | 1.8 | 0.3 | 0.2 | |
| Total Current Assets | 964.6 | 817.1 | 732.2 | 883.9 | 856.6 | 1,295.3 | 851.0 | 522.4 | 244.5 | 498.1 | 450.2 | 187.5 | 55.2 | 86.4 | 11.0 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 202.5 | 166.1 | 127.1 | 173.7 | 150.6 | 480.7 | 112.3 | 213.6 | 72.6 | 102.1 | |
| Short Term Investments | 222.7 | 311.3 | 367.4 | 436.3 | 471.0 | 283.1 | 299.8 | 363.6 | 369.5 | 449.9 | |
| Total Cash & ST Investments | 425.2 | 477.4 | 494.4 | 610.0 | 621.6 | 763.8 | 412.1 | 777.1 | 524.2 | 552.0 | |
| Accounts Receivable | 112.5 | 124.5 | 98.8 | 121.8 | 93.3 | 106.0 | 100.3 | 73.4 | 79.3 | 70.5 | |
| Inventory | 52.2 | 46.5 | 46.0 | 45.0 | 43.3 | 40.1 | 35.9 | 34.0 | 31.8 | 28.3 | |
| Other Current Assets | 53.2 | 71.4 | 59.8 | 40.3 | 41.4 | 54.7 | 47.7 | 47.6 | 46.0 | 51.4 | |
| Total Current Assets | 643.2 | 719.8 | 699.2 | 817.1 | 799.6 | 964.6 | 596.0 | 732.2 | 524.2 | 702.1 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 278.7 | 265.9 | 290.6 | 285.7 | 176.2 | 114.0 | 74.7 | 20.0 | 21.8 | 17.1 | 7.4 | 3.0 | 1.3 | 1.4 | 0.8 | |
| Goodwill | 44.4 | 44.4 | 44.4 | 44.4 | 44.4 | 44.4 | 44.4 | 44.4 | 44.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 166.2 | 178.3 | 166.3 | 160.1 | 130.8 | 131.1 | 129.0 | 129.2 | 141.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 114.1 | 135.0 | 199.9 | 154.5 | 293.9 | 165.9 | 32.9 | 0.0 | 10.0 | 118.0 | 99.3 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 50.4 | 62.7 | 57.7 | 16.8 | 20.6 | 8.8 | 3.5 | 3.5 | 3.4 | -92.5 | 2.7 | 7.4 | 3.1 | 0.5 | 0.4 | |
| Total Long-Term Assets | 653.8 | 686.3 | 758.8 | 661.5 | 665.8 | 464.3 | 284.5 | 197.2 | 246.3 | 42.5 | 109.4 | 10.5 | 4.4 | 1.9 | 1.2 | |
| Total Assets | 1,618.4 | 1,503.5 | 1,491.0 | 1,545.4 | 1,522.4 | 1,759.6 | 1,135.5 | 719.6 | 490.8 | 540.6 | 559.6 | 198.0 | 59.6 | 88.3 | 12.1 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 250.0 | 255.8 | 260.9 | 265.9 | 272.4 | 278.7 | 285.1 | 290.6 | 323.2 | 308.2 | |
| Goodwill | 44.4 | 44.4 | 44.4 | 44.4 | 44.4 | 44.4 | 44.4 | 44.4 | 44.4 | 44.4 | |
| Intangible Assets | 172.9 | 174.7 | 176.5 | 178.3 | 164.9 | 166.2 | 165.0 | 166.3 | 157.3 | 158.2 | |
| Long-Term Investments | 22.1 | 51.5 | 68.6 | 135.0 | 203.1 | 110.7 | 156.6 | 199.9 | 4.0 | 71.8 | |
| Other Long-Term Assets | 57.9 | 60.1 | 62.4 | 62.7 | 53.9 | 53.8 | 60.0 | 51.7 | 110.0 | 26.5 | |
| Total Long-Term Assets | 547.2 | 586.5 | 612.8 | 686.3 | 738.8 | 653.8 | 711.1 | 758.8 | 714.0 | 609.2 | |
| Total Assets | 1,190.4 | 1,306.3 | 1,311.9 | 1,503.5 | 1,538.4 | 1,618.4 | 1,307.1 | 1,491.0 | 1,238.1 | 1,311.3 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 59.8 | 38.8 | 42.1 | 43.3 | 17.1 | 12.9 | 12.9 | 12.3 | 8.9 | 5.4 | 2.9 | 4.9 | 1.4 | 1.2 | 0.3 | |
| Short-Term Debt | 58.6 | 10.3 | 12.6 | 11.8 | 11.1 | 9.0 | 7.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Liabilities | 154.4 | 295.1 | 225.7 | 204.7 | 145.6 | 108.5 | 83.2 | 62.5 | 56.1 | 54.9 | 25.0 | 7.7 | 4.5 | 2.0 | 0.7 | |
| Current Liabilities | 272.9 | 344.2 | 280.4 | 261.2 | 181.4 | 189.6 | 103.3 | 74.7 | 71.0 | 60.3 | 27.9 | 12.5 | 5.9 | 3.2 | 1.0 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 40.6 | 34.2 | 47.5 | 38.8 | 36.0 | 59.8 | 41.0 | 42.1 | 33.4 | 42.1 | |
| Short-Term Debt | 77.7 | 11.8 | 10.5 | 10.3 | 10.4 | 11.7 | 12.8 | 12.6 | 12.1 | 10.9 | |
| Other Current Liabilities | 221.8 | 247.2 | 233.7 | 295.1 | 238.6 | 201.3 | 191.8 | 225.7 | 208.6 | 191.4 | |
| Current Liabilities | 340.0 | 293.2 | 291.7 | 344.2 | 285.0 | 272.9 | 245.6 | 280.4 | 254.0 | 244.4 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 842.2 | 30.0 | 30.6 | 19.8 | 30.9 | 39.3 | 29.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Capital Leases | 25.7 | 40.3 | 43.2 | 31.6 | 42.0 | 48.2 | 37.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 30.1 | 30.1 | 30.1 | 31.7 | 33.3 | 33.3 | 33.3 | 31.2 | 31.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 1,186.0 | 1,241.2 | 1,215.6 | 1,193.0 | 599.8 | 605.2 | 481.7 | 110.7 | 107.3 | 66.7 | 28.5 | 13.0 | 9.5 | 4.0 | 1.5 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 785.4 | 24.5 | 27.8 | 30.0 | 23.7 | 25.7 | 28.0 | 30.6 | 34.6 | 14.8 | |
| Capital Leases | 33.8 | 36.3 | 38.3 | 40.3 | 34.1 | 37.5 | 40.8 | 43.2 | 12.1 | 25.7 | |
| Def. Tax Liability | 0.0 | 30.1 | 30.1 | 30.1 | 30.1 | 30.1 | 30.1 | 30.1 | 31.7 | 31.7 | |
| Total Liabilities | 1,174.3 | 1,148.0 | 1,160.7 | 1,241.2 | 1,184.5 | 1,186.0 | 1,166.8 | 1,215.6 | 1,206.4 | 1,182.3 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -3,689.9 | -3,956.8 | -3,387.7 | -2,781.0 | -2,073.6 | -1,619.6 | -1,433.0 | -1,030.3 | -832.7 | -530.5 | -284.7 | -139.0 | -74.8 | -27.1 | -8.2 | |
| Comprehensive Income | 2.3 | -0.6 | 0.6 | -6.6 | -1.4 | 0.7 | -0.1 | -0.6 | -5.7 | 0.9 | -0.9 | -0.2 | 0.0 | -0.4 | 0.0 | |
| Total Common Equity | 432.4 | 255.3 | 275.4 | 352.5 | 922.6 | 1,154.4 | 653.8 | 608.9 | 383.5 | 474.0 | 531.1 | 184.9 | 50.1 | 84.3 | 10.6 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| Retained Earnings | -4,403.3 | -4,222.9 | -4,107.9 | -3,956.8 | -3,823.5 | -3,689.9 | -3,558.3 | -3,387.7 | -3,264.5 | -3,104.8 | |
| Comprehensive Income | 8.8 | -0.3 | -0.3 | -0.6 | 0.9 | -1.1 | -0.4 | 0.6 | -2.2 | -3.1 | |
| Total Common Equity | 9.2 | 151.3 | 144.2 | 255.3 | 346.8 | 432.4 | 140.3 | 275.4 | 31.7 | 129.0 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 926.5 | 40.3 | 43.2 | 31.6 | 42.0 | 48.2 | 37.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 432.4 | 262.3 | 275.4 | 352.5 | 922.6 | 1,154.4 | 653.8 | 608.9 | 383.5 | 474.0 | 531.1 | 184.9 | 50.1 | 84.3 | 10.6 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 7.0 | 7.0 | 7.0 | 7.0 | 7.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 9.2 | 151.3 | 144.2 | 255.3 | 346.8 | 432.4 | 140.3 | 275.4 | 31.7 | 129.0 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -585.1 | -575.0 | -569.2 | -606.6 | -707.4 | -454.0 | -186.6 | -402.7 | -197.6 | -302.1 | -245.9 | -145.6 | -59.8 | -35.1 | -16.3 | -6.8 | |
| Depreciation & Amortization | 33.1 | 0.0 | 35.5 | 26.0 | 18.2 | 13.2 | 12.3 | 8.5 | 19.5 | 5.8 | 3.4 | 1.4 | 0.7 | 0.4 | 0.3 | 0.0 | |
| Stock-Based Compensation | 144.9 | 153.0 | 158.0 | 135.2 | 130.4 | 105.0 | 85.7 | 82.0 | 80.1 | 68.0 | 48.3 | 24.9 | 5.4 | 0.7 | 0.9 | 0.3 | |
| Change Working Capital | -23.6 | -23.0 | 13.9 | -15.1 | 60.2 | -63.2 | 104.7 | -15.9 | -24.8 | -20.2 | 26.3 | 7.7 | 2.2 | -1.5 | 2.3 | 0.5 | |
| Change In Accounts Receivable | -27.9 | -31.0 | -33.6 | -22.8 | -12.1 | -5.4 | 9.8 | -20.1 | -7.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Change In Accounts Payable | 13.1 | 24.0 | 47.0 | 2.4 | 87.4 | 2.8 | 29.6 | 20.6 | 3.4 | 3.5 | 2.5 | -2.0 | 3.2 | 0.2 | 0.9 | 0.3 | |
| Change In Inventories | -11.7 | -6.0 | -11.2 | -6.9 | -9.7 | -3.1 | -1.3 | -4.5 | -5.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Non-cash Items | 252.5 | -21.0 | -52.5 | -12.7 | 119.8 | 11.7 | 21.5 | 1.7 | -0.2 | 10.9 | 0.7 | 5.6 | 6.9 | 4.3 | 0.3 | 0.3 | |
| Cash from Operations | -469.5 | 0.0 | 0.0 | -474.8 | -380.5 | -338.7 | -132.2 | -345.4 | -290.6 | -253.8 | -161.0 | -106.0 | -44.6 | -31.2 | -12.5 | -5.8 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -129.0 | -180.4 | -115.0 | -151.1 | -133.4 | -133.5 | -131.6 | -170.7 | -123.2 | -159.6 | |
| Depreciation & Amortization | 0.0 | 8.6 | -11.8 | 9.0 | 9.1 | 8.8 | 8.9 | 8.8 | 8.2 | 7.2 | |
| Stock-Based Compensation | 38.0 | 37.0 | 38.5 | 39.9 | 40.2 | 41.6 | 39.4 | 36.9 | 33.7 | 34.9 | |
| Change Working Capital | 0.6 | 54.9 | -21.8 | -56.6 | 22.8 | 30.8 | 16.4 | -56.0 | 13.3 | 2.8 | |
| Change In Accounts Receivable | -33.8 | 5.4 | -12.7 | 10.1 | -20.6 | 9.8 | 2.2 | -24.9 | 1.0 | -6.2 | |
| Change In Accounts Payable | 37.0 | 45.1 | -9.7 | -48.5 | 0.0 | 0.0 | 25.3 | -35.5 | 15.9 | 7.5 | |
| Change In Inventories | 0.2 | -5.6 | 0.2 | -0.8 | -2.5 | -2.5 | -4.1 | -2.1 | -2.0 | -3.5 | |
| Other Non-cash Items | -9.4 | -11.5 | 1.7 | -7.7 | -18.1 | -14.6 | -10.0 | -9.8 | 123.2 | -1.8 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -83.9 | -117.9 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -23.0 | 0.0 | -7.5 | -44.3 | -146.1 | -73.1 | -43.9 | -24.8 | -4.1 | -2.8 | -10.2 | -5.0 | -2.1 | -0.4 | -1.1 | -0.5 | |
| Acquisitions | 2.5 | 0.0 | 0.0 | 0.0 | -75.0 | 0.0 | 0.0 | 0.0 | 0.0 | -142.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | -386.4 | 0.0 | -408.6 | -526.4 | -614.7 | -1,012.2 | -850.3 | -707.2 | -509.8 | -230.5 | -442.5 | -624.2 | -209.0 | -64.0 | 0.0 | 0.0 | |
| Sales of Investment | 524.5 | 0.0 | 413.3 | 746.2 | 545.1 | 890.9 | 720.6 | 719.0 | 310.2 | 431.6 | 543.8 | 338.4 | 88.0 | 16.6 | 0.0 | 0.0 | |
| Other Investing Activities | -2.8 | 0.0 | 0.0 | -7.5 | -0.8 | -0.9 | -5.6 | 0.0 | 170.3 | 0.9 | -1.2 | -1.5 | -0.3 | 0.0 | -0.1 | -0.4 | |
| Cash from Investing | 112.3 | 0.0 | 0.0 | 168.0 | -291.7 | -195.4 | -179.1 | -13.0 | -33.3 | 56.4 | 89.9 | -292.4 | -123.4 | -47.7 | -1.2 | -0.9 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | 0.0 | -1.3 | -2.5 | -1.3 | -0.7 | -1.6 | -2.0 | -3.2 | -1.6 | -3.7 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.5 | 0.0 | |
| Investments | 0.0 | 0.0 | -15.5 | 0.0 | -15.9 | -367.4 | -3.4 | -21.9 | -221.6 | -139.5 | |
| Sales of Investment | 0.0 | 0.0 | 89.4 | 137.0 | 119.4 | 93.7 | 68.5 | 131.6 | 116.4 | 207.9 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.3 | -0.4 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -107.0 | 64.3 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -4.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 900.8 | 40.3 | -2.8 | 11.6 | -10.4 | -6.3 | 11.2 | 37.0 | 0.0 | 4.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Issuance of Common Stock | 769.2 | 0.0 | 0.0 | 379.8 | 10.8 | 78.9 | 511.2 | 355.2 | 309.0 | 132.0 | 79.5 | 467.6 | 189.3 | 0.2 | 0.1 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -4.3 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 740.7 | 0.0 | 0.0 | 8.4 | 490.4 | 39.6 | 89.1 | 324.1 | 27.8 | 9.3 | 59.2 | 0.0 | 0.0 | 0.0 | 89.1 | 17.3 | |
| Cash from Financing | 740.7 | 0.0 | 0.0 | 388.1 | 501.2 | 118.6 | 600.3 | 679.3 | 336.9 | 136.3 | 138.7 | 467.6 | 185.0 | 0.2 | 89.2 | 17.3 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 863.1 | 826.8 | -2.0 | -2.1 | 6.3 | -3.4 | -3.3 | -2.4 | 31.1 | -13.7 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 326.5 | 24.8 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 4.2 | 0.4 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 330.6 | 25.2 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 387.1 | 253.5 | -35.2 | 81.8 | -172.0 | -416.7 | 290.1 | 320.7 | 12.5 | -60.6 | 67.6 | 69.2 | 16.9 | -78.8 | 75.5 | 10.6 | |
| Closing Cash Balance | 486.9 | 436.0 | 184.2 | 219.4 | 137.6 | 309.6 | 726.3 | 436.2 | 115.5 | 100.5 | 161.1 | 93.6 | 24.3 | 7.4 | 86.2 | 10.6 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 221.7 | 26.1 | 49.5 | -45.0 | 23.9 | -330.0 | 367.9 | -97.0 | 144.8 | -29.1 | |
| Closing Cash Balance | 436.0 | 214.7 | 188.6 | 139.2 | 184.2 | 160.2 | 490.3 | 122.4 | 219.4 | 78.6 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -492.5 | -472.0 | -421.7 | -521.6 | -526.6 | -411.8 | -176.1 | -370.2 | -294.6 | -256.6 | -171.2 | -110.9 | -46.8 | -31.6 | -13.6 | -6.4 | |
| Real Free Cash Flow | -637.4 | -625.0 | -579.7 | -656.8 | -657.0 | -516.7 | -261.9 | -452.2 | -374.7 | -324.7 | -219.5 | -135.8 | -52.2 | -32.3 | -14.5 | -6.6 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -100.8 | -92.7 | -95.7 | -182.8 | -80.2 | -68.6 | -81.5 | -203.9 | -85.5 | -121.6 | |
| Real Free Cash Flow | -138.8 | -129.7 | -134.3 | -222.7 | -120.3 | -110.2 | -120.8 | -240.9 | -119.2 | -156.4 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -3.4 | -15 | -1.4 |
| P/S | 3 | 5401.9 | 9.4 |
| P/B | 122.8 | 13.9 | 5.2 |
| P/FCF | -3.2 | -14.1 | -1.5 |
| Market cap | $2.9 | $3.5 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 6.3 % | 0 % |
| Debt to Income | -150 % | -16 % | 0 % |
| Debt to Free cash flow | -138 % | -672.1 % | 0 % |
| Interest expense percentage | -11.5 % | -4.1 % | 44.7 % |
| Current ratio | 1.9 | 8.2 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -6282.8 % | -245.7 % | 0 % |
| ROA | -48.3 % | -33.5 % | 0 % |
| CapEx to Revenue | 0.8 % | 1710 % | 0 % |
| RaD to Revenue | 0 % | 31302 % | 0 % |
| ROEM | 519,877.1 | 102986.4 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 83.8 % | 68.9 % | 68.7 % |
| Operating margin | -79.6 % | -41665.5 % | 35.5 % |
| Net margin | -85.5 % | -40838.7 % | 9.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | -0.7 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 99.9 mil | 55.3 mil |
| Employee count | 1.3 tis | 0.7 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
